Process for preparing a novel crystalline form of emamectin benzoate and use the same
US-2016355538-A1 · Dec 8, 2016 · US
US9137992B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9137992-B2 |
| Application number | US-201314082494-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 18, 2013 |
| Priority date | Feb 19, 2002 |
| Publication date | Sep 22, 2015 |
| Grant date | Sep 22, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides, biologically active spinosyns, hybrid spinosyn polyketide synthases capable of functioning in Saccharopolyspora spinosa to produce the spinosyns, and methods of controlling insects using the spinosyns.
Opening claim text (preview).
What is claimed is: 1. A compound of the formula (I) wherein R1 is hydrogen, methyl, or ethyl; R2 is hydrogen, methyl, or ethyl; R3 is hydrogen, R4 is methyl or ethyl, either of which may be substituted with one or more groups selected from halo, hydroxy, C 1…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.